[1]孙治坤,马兴荣,陈 帅,等.丁苯酞对糖尿病合并阿尔茨海默病大鼠记忆能力的影响[J].新乡医学院学报,2021,38(2):112-117.[doi:10.7683/xxyxyxb.2021.02.003]
 SUN Zhikun,MA Xingrong,CHEN Shuai,et al.Effect of butylphthalide on the memory ability of rats with diabetes mellitus and Alzheimer′s disease[J].Journal of Xinxiang Medical University,2021,38(2):112-117.[doi:10.7683/xxyxyxb.2021.02.003]
点击复制

丁苯酞对糖尿病合并阿尔茨海默病大鼠记忆能力的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年2
页码:
112-117
栏目:
基础研究
出版日期:
2021-02-05

文章信息/Info

Title:
Effect of butylphthalide on the memory ability of rats with diabetes mellitus and Alzheimer′s disease
作者:
孙治坤1马兴荣2陈 帅1贺 爽1张杰文1
(1.河南省人民医院神经内科,河南 郑州 4500032.郑州大学第一附属医院神经内科,河南 郑州 450052)
Author(s):
SUN Zhikun1MA Xingrong2CHEN Shuai1HE Shuang1ZHANG Jiewen1
(1.Department of Neurology,Henan Provincial People′s Hospital,Zhengzhou 450003,Henan Province,China2.Department of Neurology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,Henan Province,China)
关键词:
阿尔茨海默病糖尿病丁苯酞氧化应激炎症反应
Keywords:
Alzheimer′s diseasediabetes mellitusbutylphthalideoxidative stressinflammatory
分类号:
R332;R749.16
DOI:
10.7683/xxyxyxb.2021.02.003
文献标志码:
A
摘要:
目的 探讨丁苯酞对糖尿病合并阿尔茨海默病大鼠记忆能力的影响。方法 将32只健康Wistar大鼠随机分为空白对照组、模型组、丁苯酞对照组及丁苯酞治疗组,每组8只。模型组和丁苯酞治疗组大鼠腹腔内注射链脲佐菌素(55 mg·kg-1)制备糖尿病模型,然后在大鼠双侧海马组织中注射凝集态的β-淀粉样蛋白制备糖尿病合并阿尔茨海默病模型;空白对照组和丁苯酞对照组大鼠腹腔内注射等体积柠檬酸缓冲液,然后双侧海马组织中注射等体积生理盐水。丁苯酞对照组和丁苯酞治疗组大鼠分别于造模后1周开始灌胃给予丁苯酞(80 mg·kg-1),每日2次,连续给药4周;空白对照组和模型组大鼠每日给予等量的玉米油灌胃。采用Morris水迷宫实验评估各组大鼠学习记忆能力;采用比色法检测各组大鼠大脑皮层和海马组织中乙酰胆碱酯酶(AchE)、胆碱乙酰转移酶(ChAT)、超氧化物歧化酶(SOD)活性及丙二醛(MDA)、谷胱甘肽(GSH)水平;采用酶联免疫吸附试验检测各组大鼠海马组织中白细胞介素(IL)-1β、IL-6水平。结果 丁苯酞对照组与空白对照组大鼠逃避潜伏期、游泳距离、在目标象限中游泳时间百分比和游泳距离百分比、海马组织中IL-1β和IL-6水平及大脑皮层和海马组织中AchE、ChAT、SOD活性、MDA、GSH水平比较差异均无统计学意义(P>0.05)。训练前3 d,4组大鼠逃避潜伏期及游泳距离比较差异均无统计学意义(P>0.05);训练第4天,模型组大鼠逃避潜伏期和游泳距离均长于空白对照组(P<0.05);丁苯酞治疗组大鼠逃避潜伏期和游泳距离均短于模型组(P<0.05)。模型组大鼠在目标象限内游泳时间百分比和游泳距离百分比均显著低于空白对照组(P<0.05);丁苯酞治疗组大鼠在目标象限内游泳时间百分比和游泳距离百分比均显著高于模型组(P<0.05)。与空白对照组比较,模型组大鼠大脑皮层和海马组织中AchE活性及MDA水平显著升高,SOD、ChAT活性及 GSH水平显著降低(P<0.05)。与模型组比较,丁苯酞治疗组大鼠大脑皮层和海马组织中AchE活性及MDA水平显著降低,SOD、ChAT活性及GSH水平显著升高(P<0.05)。模型组大鼠海马组织中IL-1β、IL-6水平显著高于空白对照组(P<0.05)丁苯酞治疗组大鼠海马组织中L-1β、IL-6水平显著低于模型组(P<0.05)。结论 丁苯酞可显著减轻糖尿病合并阿尔茨海默病大鼠的记忆能力损伤,其作用机制可能与减轻脑内的氧化应激及炎症反应有关。
Abstract:
Objective To investigate the effect of butylphthalide on memory ability of rats with diabetes mellitus and Alzheimer′s disease.Methods  Thirty-two healthy Wistar rats were randomly divided into blank control group,model group,butylphthalide control group and butylphthalide treatment group,with 8 rats in each group.The rats in the model group and butylphthalide treatment group were intraperitoneally injected with streptozotocin (55 mg·kg-1) to make the diabetes mellitus model,and then the agglutinated β-amyloid was injected into the bilateral hippocampus of rats to establish the model of diabetes mellitus with Alzheimer′s disease;the rats in the blank control group and butylphthalide control group were intraperitoneally injected with equal volume of citric acid buffer,and then were injected with equal volume of normal saline into the bilateral hippocampus.Rats in the butylphthalide control group and butylphthalide treatment group were given butylphthalide (80 mg·kg-1) by gavage twice a day for 4 weeks after modeling;the rats in the blank control group and model group were given the same amount of corn oil by gavage every day.The learning and memory ability of rats in each group was measured by Morris water maze test;the activities of acetylcholinesterase (AchE),choline acetyltransferase (ChAT),superoxide dismutase (SOD) and the levels of malondialdehyde (MDA),glutathione (GSH) in cerebral cortex and hippocampus of rats in each group were detected by colorimetric method;the levels of interleukin(IL)-1β and IL-6 in hippocampus of rats was detected by enzyme linked immunosorbent assay.Results There was no significant difference in the escape latency,swimming distance,Percentage of swimming time and swimming distance in target quadrant,levels of IL-1β and IL-6 in hippocampus,activities of AchE,ChAT,SOD in cerebral cortex and hippocampus,levels of MDA,GSH in cerebral cortex and hippocampus of rats between the butylphthalide control group and blank control group (P>0.05).There was no significant difference in escape latency and swimming distance of rats among the four groups in 3 days before training (P>0.05).On the fourth day of training,the escape latency and swimming distance of rats in the model group were longer than those in the blank trol group (P<0.05);the escape latency and swimming distance of rats in the butylphthalide treatment group were shorter than those in the model group (P<0.05).The percentage of swimming time and swimming distance in the target quadrant of rats in the model group were significantly lower than those in the blank control group (P<0.05);the percentage of swimming time and swimming distance in the target quadrant of rats in the butylphthalide treatment group were significantly higher than those in the model group (P<0.05).Compared with blank control group,the AchE activity and MDA levels in cerebral cortex and hippocampus of rats in the model group were significantly increased,and the SOD,ChAT activity and GSH levels were significantly decreased (P<0.05).Compared with the model group,the AchE activity and MDA levels in cerebral cortex and hippocampus of rats in butylphthalide treatment group were significantly decreased,and the SOD,ChAT activity and GSH levels were significantly increased (P<0.05).The levels of IL-1β and IL-6 in hippocampus of rats in the model group were significantly higher than those in the blank control group (P<0.05).The levels of IL-1β and IL-6 in hippocampus of rats in the butylphthalide treatment group were significantly lower than those in the model group (P<0.05).Conclusion Butylphthalide can significantly reduce the memory impairment of rats with diabetes mellitus and Alzheimer′s disease,and its mechanism may be related to the reduction of oxidative stress and inflammatory reaction in the brain.

参考文献/References:

[1] 耿艳娜,陈清光,张博渊,等.糖尿病与阿尔茨海默病相关性研究进展[J].中国老年学杂志,2017,37(8):2063-2065.
[2] 马蕾亚,胡为民.阿尔茨海默病与糖尿病的关系及治疗新进展[J].中华老年医学杂志,2015,34(9):1037-1041.
[3] GUDALA K,BANSAL D,SCHIFANO F,et al.Diabetes mellitus and risk of dementia:a meta-analysis of prospective observational studies[J].J Diabetes Investig,2013,4(6):640-650.
[4] XU Z Q,ZHOU Y,SHAO B Z,et al.A systematic review of neuroprotective efficacy and safety of DL-3-N-butylphthalide in ischemic stroke[J].Am J Chin Med,2019,47(3):507-525.
[5] ZHOU H,YE M,XU W,et al.DL-3-n-butylphthalide therapy for Parkinson′s disease:a randomized controlled trial[J].Exp Ther Med,2019,17(5):3800-3806.
[6] QI Q,XU J,LV P,et al.DL-3-n-butylphthalide alleviates vascular cognitive impairment induced by chronic cerebral hypoperfusion by activating the Akt/Nrf2 signaling pathway in the hippocampus of rats[J].Neurosci Lett,2018,672:59-64.
[7] SONG F X,WANG L,LIU H,et al.Brain cell apoptosis inhibition by butylphthalide in Alzheimer′s disease model in rats[J].Exp Ther Med,2017,13(6):2771-2774.
[8] 孙治坤,马兴荣,韩笑,等.白藜芦醇对阿尔茨海默病合并糖尿病大鼠的氧化应激作用[J].中国实用神经疾病杂志,2017,20(23):1-5.
[9] 侯立维,孔丽娜,杜开先.外源性胆红素对缺血缺氧性脑损伤大鼠认知功能及海马中蛋白酪氨酸激酶2/信号转导子与激活子3/B细胞淋巴瘤基因-2通路的影响[J].新乡医学院学报,2018,35 (12):1052-1057.
[10] 赵敏,孔彦莹,严华成,等.CYP46A1过表达对阿尔茨海默病转基因模型小鼠的认知改善和抗炎症作用[J].解放军医学杂志,2018,43(4):271-277.
[11] 郭珂一,李清华,柯尊记.黄芪散对阿尔茨海默病的防治作用研究进展[J].新乡医学院学报,2020,37(5):489-493.
[12] WIMO A,JONSSON L,WINBLAD B.An estimate of the worldwide prevalence and direct costs of dementia in 2003[J].Dement Geriatr Cogn Disord,2006,21(3):175-181.
[13] ALZHEIMER′S ASSOCIATION.2019 Alzheimer′s disease facts and figures[J].Alzheimers Dement,2019,15(3):321-387.
[14] CHO N H,SHAW J E,KARURANGA S,et al.IDF diabetes atlas:global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018,138:271-281.
[15] XING X,HUANG L,LV Y,et al.DL-3-n-butylphthalide protected retinal muller cells dysfunction from oxidative stress[J].Curr Eye Res,2019,44(10):1112-1120.
[16] HE Z,ZHOU Y,HUANG Y,et al.Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosis[J].Am J Transl Res,2017,9(3):1075-1087.
[17] YAN H,YAN Z,NIU X,et al.DL-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke:a prospective intervention study[J].Neurol Res,2017,39(4):337-343.
[18] JIA J,WEI C,LIANG J,et al.The effects of DL-3-n-butylph-thalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease:a multicentre,randomized,double-blind,placebo-controlled trial[J].Alzheimers Dement,2016,12(2):89-99.
[19] WANG H M,ZHANG T,HUANG J K,et al.3-N-butylphthalide (NBP) attenuates the amyloid-beta-induced inflammatory responses in cultured astrocytes via the nuclear factor-kappaB signaling pathway[J].Cell Physiol Biochem,2013,32(1):235-242.
[20] SONG F X,WANG L,LIU H,et al.Brain cell apoptosis inhibition by butylphthalide in Alzheimer′s disease model in rats[J].Exp Ther Med,2017,13(6):2771-2774.
[21] PENG Y,HU Y,XU S,et al.DL-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AbetaPP/PS1-Alzheimer′s transgenic mice[J].J Alzheimers Dis,2012,29(2):379-391.
[22] WANG F,MA J,HAN F,et al.DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model[J].Sci Rep,2016,6:19396.
[23] ZHANG T,JIA W,SUN X.3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats[J].Neurol Res,2010,32(4):390-396.
[24] 王灿,吴慧杰,李金遥,等.阿尔茨海默病与糖尿病共同发病机制的研究进展[J].中风与神经疾病杂志,2017,34(8):766-768.
[25] 陈莹恩,杨秀丽,赵奕霖,等.辛伐他汀对慢性心力衰竭幼兔心肌凋亡及氧化应激机制的影响[J].中华实用儿科临床杂志,2017,32(13):1022-1025.
[26] 王艳萍,华颖,王健彪,等.手足口病并脑炎患儿白细胞介素-1β、水通道蛋白4变化的意义[J].中华实用儿科临床杂志,2018,33(18):1407-1410.

相似文献/References:

[1]陈翀,李晓红,涂悦,等.糖原合成酶激酶3对大鼠创伤性脑损伤后认知功能的影响[J].新乡医学院学报,,():000.
[2]马晓军,霍慧春,刘娟,等.针灸联合中药对糖尿病大鼠血脂及血糖的调节作用[J].新乡医学院学报,,():000.
[3]陈翀,李晓红,涂悦,等.糖原合成酶激酶3对大鼠创伤性脑损伤后认知功能的影响[J].新乡医学院学报,,():000.
[4]郭永年.糖尿病氯磺丙脲酒精潮红试验[J].新乡医学院学报,1986,3(02):064.
[5]翁孝刚,郭永年,王宪波,等.复方中药渴乐饮对实验大鼠体重及血糖的影响 [J].新乡医学院学报,1994,11(02):107.
[6]郭永年,李灵敏,王伟,等.新光碘蛋的研制及其对糖尿病患者的保健作用 [J].新乡医学院学报,1994,11(04):339.
[7]翁孝刚,王宪波,郭永年,等.复方中药渴乐饮对实验大鼠胰岛B细胞形态及功能的影响[J].新乡医学院学报,1994,11(04):351.
[8]王宪波,翁孝刚,王伟,等.复方中药渴乐饮对实验大鼠的抗氧化抗疲劳作用[J].新乡医学院学报,1994,11(04):354.
[9]翁孝钢,梁荩忠,吴兆锋,等.链脲菌素实验性糖尿病大鼠组织钙调素活性的研究[J].新乡医学院学报,1995,12(03):201.
[10]王宪波,翁孝钢,郭永年,等.复方中药渴乐对实验糖尿病大鼠血脂的影响[J].新乡医学院学报,1995,12(01):018.

更新日期/Last Update: 2021-02-05